DEFA14A: Tevogen Bio Announces 2025 Annual Meeting of Stockholders

Tevogen Bio will hold its 2025 annual meeting of stockholders via live webcast on June 23, 2025, to vote on director re-election and ratification of the company's accounting firm.

Summary

• Tevogen Bio Holdings Inc. will hold its 2025 Annual Meeting of Stockholders on June 23, 2025, via live webcast.
• Stockholders of record as of April 30, 2025, will vote on the re-election of two incumbent director nominees and the ratification of the company's independent registered public accounting firm.
• Proxy materials will be distributed to stockholders of record as of April 30, 2025, in accordance with SEC regulations.
• Stockholders can vote their shares at the Annual Meeting if they provide their 16-digit control number.
• The company intends to disclose the Annual Meeting voting results on a Form 8-K following the meeting.
• The company will file a proxy statement on Schedule 14A with the SEC, which will be mailed to stockholders of record as of April 30, 2025.

Sentiment

Score: 7

Explanation: The document is a standard announcement of an annual meeting, which is generally neutral. The information is presented in a factual and straightforward manner.

Positives

• The company is providing stockholders with the opportunity to participate in the Annual Meeting via live webcast.
• The company is adhering to SEC regulations regarding the distribution of proxy materials.
• The company is committed to disclosing the Annual Meeting voting results promptly.

Future Outlook

The company intends to disclose the Annual Meeting voting results on a Form 8-K following the Annual Meeting.

Industry Context

This announcement is a routine part of corporate governance, ensuring shareholders have the opportunity to vote on key company matters.

Stakeholder Impact

• Shareholders can vote on important company matters.
• The company is providing information to shareholders in accordance with SEC regulations.

Next Steps

• Distribution of proxy materials to stockholders of record as of April 30, 2025.
• Filing of the proxy statement on Schedule 14A with the SEC.
• Holding the Annual Meeting on June 23, 2025.
• Disclosure of the Annual Meeting voting results on a Form 8-K.

Key Dates

Keywords

Annual Meeting, Stockholders, Proxy Statement, Tevogen Bio, Voting, Directors, Accounting Firm